How long must nuclear pharmacies keep records of radiopharmaceutical acquisition and disposition?

Nuclear pharmacies are required to maintain records of the acquisition and disposition of radiopharmaceuticals for a period of three years. This requirement aligns with regulatory standards designed to ensure proper record-keeping for controlled substances, including those used in nuclear medicine. Maintaining these records is crucial for regulatory compliance, facilitating accountability, and ensuring patient safety.

The three-year timeline allows for adequate tracking of radiopharmaceuticals, supporting both patient treatment continuity and compliance with pharmacy regulations. By keeping these detailed logs, pharmacies confirm the proper handling and distribution of these substances, which may be subject to additional scrutiny due to their unique properties and the handling methods required for safe disposal and patient administration.

Other timelines such as one year or five years do not reflect the current regulatory standards specific to nuclear pharmacies, which is why three years is the correct duration stipulated for these records.